Neuroprotective molecules such as hepatocyte growth factor, brain-derived neurotrophic factor (BDNF), fibroblast growth factor, nerve growth factor [20], and IGF-1 [9] have been applied for SCA3 animal model treatment and assessed in human trials [35,54]. Here, BDNF is linked to Spinocerebellar ataxia type 3.